DHR Health Fully Operational Amid Cybersecurity Incident

Translate to Spanish or other 102 languages!

Image courtesy of DHR Health

Mega Doctor News

- Advertisement -

DHR Health, a leading healthcare provider, confirms it is fully operational and continues providing uninterrupted patient care amid a recent cybersecurity incident affecting its information systems.

In a statement issued to media partners, DHR Health emphasized its swift and proactive response:

“DHR Health is currently addressing a cyber incident affecting our information systems. Our dedicated IT teams are actively working to restore full functionality as quickly as possible.

- Advertisement -

Patient care remains our highest priority and continues without disruption. We have well-established backup protocols in place to ensure seamless operations, and our staff is fully equipped to manage the situation effectively.

We appreciate the patience and support of our patients, staff, and community. We will remain open to serve our community.”

DHR Health reassures all patients and community members that established safety measures and backup protocols are in place to ensure seamless medical services. The hospital remains fully open and operational, maintaining the highest standards of patient care without interruption.

Further updates will be provided as the situation develops.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

STHS Children’s Marks 20th Anniversary with Gala Honoring Pediatric Providers Behind Its Success

For the past 20 years, South Texas Health System Children’s has stood as a place where compassionate care and clinical excellence come together to create hope for children and their families.
- Advertisement -